MedPath

Safety and Effectiveness of Sculptra Aesthetic for Correction of Nasolabial Folds.

Not Applicable
Completed
Conditions
Nasolabial Folds
Interventions
Device: Sculptra Aesthetic 8ml
Device: Sculptra Aesthetic 5ml
Registration Number
NCT03780244
Lead Sponsor
Galderma R&D
Brief Summary

This study has been designed to evaluate the safety of Sculptra Aesthetic as a single regimen for correction of Nasolabial Fold (NLF) contour deficiencies after changes in reconstitution and injection procedures compared to the approved label.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Intent to undergo correction of both left and right NLFs with a Wrinkle Assessment Scale (WAS) score of greater than or equal to 2 (shallow wrinkles) to less than or equal to 4 (deep wrinkles) as assessed on Day 1 (and also at screening, if screening was performed prior to Day 1) by the Blinded Evaluator. A one grade difference between sides is allowed at inclusion.
Exclusion Criteria
  • Previous tissue augmenting therapy, contouring or revitalization treatment in or near the treatment area with any filler prior to Baseline visit.

    1. Collagen, Hyaluronic Acid- 12 months
    2. Calcium Hydroxyapatite (CaHa), Poly-L-lactic Acid (PLLA) or permanent (non-biodegradable)- Prohibited
  • Known/previous allergy or hypersensitivity to any of the Sculptra Aesthetic constituents.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Investigational Study ProductSculptra Aesthetic 8mlInjection with Sculptra Aesthetic reconstituted with 8ml Sterile Water for Injection (SWFI)
Reference ProductSculptra Aesthetic 5mlInjection with Sculptra Aesthetic reconstituted with 5ml SWFI
Primary Outcome Measures
NameTimeMethod
Change in Wrinkle Assessment Scale (WAS) Score48 weeks

The WAS is a validated photograph-based outcome instrument that is designed specifically for quantifying facial folds. Scoring of NLF wrinkle severity (grades 0-5, with 0 representing no wrinkles and 5 representing very deep wrinkles, redundant fold) was based on visual live assessment by the Blinded Evaluator at defined timepoints and not on a comparison to the baseline appearance.

Effectiveness is defined as change from baseline on both sides of the face using WAS at 48 Weeks after the first treatment session.

Secondary Outcome Measures
NameTimeMethod
Subject Satisfaction With Treatment: Does the Treatment Make You Look/Feel More Confident in Your Life?Week 16, 24, 32, 40 and 48

A 5-point subject satisfaction questionnaire with the following responses: Very Satisfied, Satisfied, Neutral, Dissatisfied, Very Dissatisfied.

Subject Satisfaction With Treatment: Would You do the Treatment Again?Week 16, 24, 32, 40 and 48

A subject satisfaction question with responses Yes or No.

Earliest Time the Subject Reported Feeling Comfortable Returning to Social Engagement Based on Subject Diary Reportingtime in hours from treatment procedure after treatments 1,2,3 and 4 at weeks 0, 4, 8, and 12

Subjects were asked to complete the following questions in the subject diary:

* Did you feel comfortable to return to social engagement today? (Yes or No)

* If yes, what was the earliest time you felt comfortable to return to social engagement? (Record date and time \[using 24-hour clock\])

Responder Rate Based on the Global Aesthetic Improvement Scale, Treating Investigator AssessmentWeeks 16, 24, 32, 40 and 48

Responders defined as at least "improved" (improved, much improved, very much improved) as assessed by the Treating Investigator

Subject Satisfaction With Treatment: Does the Treatment Improve Your Attractiveness?Week 16, 24, 32, 40 and 48

A 5-point subject satisfaction questionnaire with the following responses: Very Satisfied, Satisfied, Neutral, Dissatisfied, Very Dissatisfied.

Subject Satisfaction With Treatment: Would You Say the Subtle Treatment Results Over Time Was Worth it?Week 16, 24, 32, 40 and 48

A 5-point subject satisfaction questionnaire with the following responses: Strongly Agree, Agree, Neither Agree Nor Disagree, Disagree, Strongly Disagree.

Change in Wrinkle Assessment Scale (WAS) ScoreWeeks 16, 24, 32, and 40

The WAS is a validated photograph-based outcome instrument that is designed specifically for quantifying facial folds. Scoring of NLF wrinkle severity (grades 0-5, with 0 representing no wrinkles and 5 representing very deep wrinkles, redundant fold) was based on visual live assessment by the Blinded Evaluator at defined timepoints and not on a comparison to the baseline appearance.

Effectiveness is defined as change from baseline on both sides of the face as assessed by the Blinded Evaluator using WAS at X weeks

Responder Rate Based on Global Aesthetic Improvement Scale, Subject AssessmentWeeks 16, 24, 32, 40, and 48.

Responders defined as at least "improved" (improved, much improved, very much improved) as assessed by the subject

FACE-Q Appraisal of Lines Rasch Transformed Total Scores: NLF QuestionnaireBaseline and at weeks 24, 32, 40 and 48

Subjects' satisfaction using the validated FACE-Q Scale, Rasch-transformed total score (0-100) according to the FACE-Q manual; the higher total score indicated greater subject satisfaction

Satisfaction With Treatment: Does the Treatment Make You Look Younger?Week 16, 24, 32, 40 and 48

A 5-point subject satisfaction questionnaire with the following responses: Very Satisfied, Satisfied, Neutral, Dissatisfied, Very Dissatisfied.

Subject Satisfaction With Treatment; Does the Treatment Make You Feel Better About Yourself?Week 16, 24, 32, 40 and 48

A 5-point subject satisfaction questionnaire with the following responses: Very Satisfied, Satisfied, Neutral, Dissatisfied, Very Dissatisfied.

Subject Satisfaction With Treatment: Does the Treatment Improve Your Self-confidence?Week 16, 24, 32, 40 and 48

A 5-point subject satisfaction questionnaire with the following responses: Very Satisfied, Satisfied, Neutral, Dissatisfied, Very Dissatisfied.

Subject Satisfaction With Treatment: Does the Treatment Improve Overall Satisfaction With Your Appearance?Week 16, 24, 32, 40 and 48

A 5-point subject satisfaction questionnaire with the following responses: Very Satisfied, Satisfied, Neutral, Dissatisfied, Very Dissatisfied.

Subject Satisfaction With Treatment: Does the Treatment Make You Look the Way You Feel?Week 16, 24, 32, 40 and 48

A 5-point subject satisfaction questionnaire with the following responses: Very Satisfied, Satisfied, Neutral, Dissatisfied, Very Dissatisfied.

Subject Satisfaction With Treatment: Does the Treatment Improve Your Facial Symmetry/Balance?Week 16, 24, 32, 40 and 48

A 5-point subject satisfaction questionnaire with the following responses: Very Satisfied, Satisfied, Neutral, Dissatisfied, Very Dissatisfied.

Subject Satisfaction With Treatment: Would You Say the Treatment Results Are Natural Looking?Week 16, 24, 32, 40 and 48

A 5-point subject satisfaction questionnaire with the following responses: Strongly Agree, Agree, Neither Agree Nor Disagree, Disagree, Strongly Disagree.

Subject Satisfaction With Treatment: Would You Recommend the Treatment to a Friend?Week 16, 24, 32, 40 and 48

A subject satisfaction question with responses Yes or No.

Trial Locations

Locations (1)

Galderma Study Site

🇺🇸

Spring, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath